Nanopharmaceuticals as a solution to neglected diseases: Is it possible?

Autores
Islan, German Abel; Durán, Marcela; Cacicedo, Maximiliano Luis; Nakazato, Gerson; Kobayashi, Renata K. T.; Martinez, Diego S. T.; Castro, Guillermo Raul; Durán, Nelson
Año de publicación
2017
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
The study of neglected diseases has not received much attention, especially from public and private institutions over the last years, in terms of strong support for developing treatment for these diseases. Support in the form of substantial amounts of private and public investment is greatly needed in this area. Due to the lack of novel drugs for these diseases, nanobiotechnology has appeared as an important new breakthrough for the treatment of neglected diseases. Recently, very few reviews focusing on filiarasis, leishmaniasis, leprosy, malaria, onchocerciasis, schistosomiasis, trypanosomiasis, and tuberculosis, and dengue virus have been published. New developments in nanocarriers have made promising advances in the treatment of several kinds of diseases with less toxicity, high efficacy and improved bioavailability of drugs with extended release and fewer applications. This review deals with the current status of nanobiotechnology in the treatment of neglected diseases and highlights how it provides key tools for exploring new perspectives in the treatment of a wide range of diseases.
Fil: Islan, German Abel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Investigación y Desarrollo en Fermentaciones Industriales. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Investigación y Desarrollo en Fermentaciones Industriales; Argentina
Fil: Durán, Marcela. Universidade Estadual de Campinas; Brasil
Fil: Cacicedo, Maximiliano Luis. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Investigación y Desarrollo en Fermentaciones Industriales. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Investigación y Desarrollo en Fermentaciones Industriales; Argentina
Fil: Nakazato, Gerson. Universidade Estadual de Londrina; Brasil
Fil: Kobayashi, Renata K. T.. Universidade Estadual de Londrina; Brasil
Fil: Martinez, Diego S. T.. Universidade Estadual de Campinas; Brasil
Fil: Castro, Guillermo Raul. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Investigación y Desarrollo en Fermentaciones Industriales. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Investigación y Desarrollo en Fermentaciones Industriales; Argentina
Fil: Durán, Nelson. Universidade Estadual de Campinas; Brasil
Materia
LIPOSOMES
NANOBIOTECHNOLOGY
NANOEMULSIONS
NANOPARTICLES
NEGLECTED DISEASES
SOLID LIPID NANOPARTICLES
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/49424
Acceder
id CONICETDig_e421ffe794a1e75c90fc277ccf1a0599
oai_identifier_str oai:ri.conicet.gov.ar:11336/49424
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Nanopharmaceuticals as a solution to neglected diseases: Is it possible?Islan, German AbelDurán, MarcelaCacicedo, Maximiliano LuisNakazato, GersonKobayashi, Renata K. T.Martinez, Diego S. T.Castro, Guillermo RaulDurán, NelsonLIPOSOMESNANOBIOTECHNOLOGYNANOEMULSIONSNANOPARTICLESNEGLECTED DISEASESSOLID LIPID NANOPARTICLEShttps://purl.org/becyt/ford/2.9https://purl.org/becyt/ford/2The study of neglected diseases has not received much attention, especially from public and private institutions over the last years, in terms of strong support for developing treatment for these diseases. Support in the form of substantial amounts of private and public investment is greatly needed in this area. Due to the lack of novel drugs for these diseases, nanobiotechnology has appeared as an important new breakthrough for the treatment of neglected diseases. Recently, very few reviews focusing on filiarasis, leishmaniasis, leprosy, malaria, onchocerciasis, schistosomiasis, trypanosomiasis, and tuberculosis, and dengue virus have been published. New developments in nanocarriers have made promising advances in the treatment of several kinds of diseases with less toxicity, high efficacy and improved bioavailability of drugs with extended release and fewer applications. This review deals with the current status of nanobiotechnology in the treatment of neglected diseases and highlights how it provides key tools for exploring new perspectives in the treatment of a wide range of diseases.Fil: Islan, German Abel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Investigación y Desarrollo en Fermentaciones Industriales. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Investigación y Desarrollo en Fermentaciones Industriales; ArgentinaFil: Durán, Marcela. Universidade Estadual de Campinas; BrasilFil: Cacicedo, Maximiliano Luis. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Investigación y Desarrollo en Fermentaciones Industriales. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Investigación y Desarrollo en Fermentaciones Industriales; ArgentinaFil: Nakazato, Gerson. Universidade Estadual de Londrina; BrasilFil: Kobayashi, Renata K. T.. Universidade Estadual de Londrina; BrasilFil: Martinez, Diego S. T.. Universidade Estadual de Campinas; BrasilFil: Castro, Guillermo Raul. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Investigación y Desarrollo en Fermentaciones Industriales. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Investigación y Desarrollo en Fermentaciones Industriales; ArgentinaFil: Durán, Nelson. Universidade Estadual de Campinas; BrasilElsevier Science2017-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/49424Islan, German Abel; Durán, Marcela; Cacicedo, Maximiliano Luis; Nakazato, Gerson; Kobayashi, Renata K. T.; et al.; Nanopharmaceuticals as a solution to neglected diseases: Is it possible?; Elsevier Science; Acta Tropica; 170; 6-2017; 16-420001-706XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.actatropica.2017.02.019info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0001706X16301917info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-22T11:10:22Zoai:ri.conicet.gov.ar:11336/49424instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-22 11:10:22.808CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
title Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
spellingShingle Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
Islan, German Abel
LIPOSOMES
NANOBIOTECHNOLOGY
NANOEMULSIONS
NANOPARTICLES
NEGLECTED DISEASES
SOLID LIPID NANOPARTICLES
title_short Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
title_full Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
title_fullStr Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
title_full_unstemmed Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
title_sort Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
dc.creator.none.fl_str_mv Islan, German Abel
Durán, Marcela
Cacicedo, Maximiliano Luis
Nakazato, Gerson
Kobayashi, Renata K. T.
Martinez, Diego S. T.
Castro, Guillermo Raul
Durán, Nelson
author Islan, German Abel
author_facet Islan, German Abel
Durán, Marcela
Cacicedo, Maximiliano Luis
Nakazato, Gerson
Kobayashi, Renata K. T.
Martinez, Diego S. T.
Castro, Guillermo Raul
Durán, Nelson
author_role author
author2 Durán, Marcela
Cacicedo, Maximiliano Luis
Nakazato, Gerson
Kobayashi, Renata K. T.
Martinez, Diego S. T.
Castro, Guillermo Raul
Durán, Nelson
author2_role author
author
author
author
author
author
author
dc.subject.none.fl_str_mv LIPOSOMES
NANOBIOTECHNOLOGY
NANOEMULSIONS
NANOPARTICLES
NEGLECTED DISEASES
SOLID LIPID NANOPARTICLES
topic LIPOSOMES
NANOBIOTECHNOLOGY
NANOEMULSIONS
NANOPARTICLES
NEGLECTED DISEASES
SOLID LIPID NANOPARTICLES
purl_subject.fl_str_mv https://purl.org/becyt/ford/2.9
https://purl.org/becyt/ford/2
dc.description.none.fl_txt_mv The study of neglected diseases has not received much attention, especially from public and private institutions over the last years, in terms of strong support for developing treatment for these diseases. Support in the form of substantial amounts of private and public investment is greatly needed in this area. Due to the lack of novel drugs for these diseases, nanobiotechnology has appeared as an important new breakthrough for the treatment of neglected diseases. Recently, very few reviews focusing on filiarasis, leishmaniasis, leprosy, malaria, onchocerciasis, schistosomiasis, trypanosomiasis, and tuberculosis, and dengue virus have been published. New developments in nanocarriers have made promising advances in the treatment of several kinds of diseases with less toxicity, high efficacy and improved bioavailability of drugs with extended release and fewer applications. This review deals with the current status of nanobiotechnology in the treatment of neglected diseases and highlights how it provides key tools for exploring new perspectives in the treatment of a wide range of diseases.
Fil: Islan, German Abel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Investigación y Desarrollo en Fermentaciones Industriales. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Investigación y Desarrollo en Fermentaciones Industriales; Argentina
Fil: Durán, Marcela. Universidade Estadual de Campinas; Brasil
Fil: Cacicedo, Maximiliano Luis. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Investigación y Desarrollo en Fermentaciones Industriales. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Investigación y Desarrollo en Fermentaciones Industriales; Argentina
Fil: Nakazato, Gerson. Universidade Estadual de Londrina; Brasil
Fil: Kobayashi, Renata K. T.. Universidade Estadual de Londrina; Brasil
Fil: Martinez, Diego S. T.. Universidade Estadual de Campinas; Brasil
Fil: Castro, Guillermo Raul. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Investigación y Desarrollo en Fermentaciones Industriales. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Investigación y Desarrollo en Fermentaciones Industriales; Argentina
Fil: Durán, Nelson. Universidade Estadual de Campinas; Brasil
description The study of neglected diseases has not received much attention, especially from public and private institutions over the last years, in terms of strong support for developing treatment for these diseases. Support in the form of substantial amounts of private and public investment is greatly needed in this area. Due to the lack of novel drugs for these diseases, nanobiotechnology has appeared as an important new breakthrough for the treatment of neglected diseases. Recently, very few reviews focusing on filiarasis, leishmaniasis, leprosy, malaria, onchocerciasis, schistosomiasis, trypanosomiasis, and tuberculosis, and dengue virus have been published. New developments in nanocarriers have made promising advances in the treatment of several kinds of diseases with less toxicity, high efficacy and improved bioavailability of drugs with extended release and fewer applications. This review deals with the current status of nanobiotechnology in the treatment of neglected diseases and highlights how it provides key tools for exploring new perspectives in the treatment of a wide range of diseases.
publishDate 2017
dc.date.none.fl_str_mv 2017-06
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/49424
Islan, German Abel; Durán, Marcela; Cacicedo, Maximiliano Luis; Nakazato, Gerson; Kobayashi, Renata K. T.; et al.; Nanopharmaceuticals as a solution to neglected diseases: Is it possible?; Elsevier Science; Acta Tropica; 170; 6-2017; 16-42
0001-706X
CONICET Digital
CONICET
url http://hdl.handle.net/11336/49424
identifier_str_mv Islan, German Abel; Durán, Marcela; Cacicedo, Maximiliano Luis; Nakazato, Gerson; Kobayashi, Renata K. T.; et al.; Nanopharmaceuticals as a solution to neglected diseases: Is it possible?; Elsevier Science; Acta Tropica; 170; 6-2017; 16-42
0001-706X
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1016/j.actatropica.2017.02.019
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0001706X16301917
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier Science
publisher.none.fl_str_mv Elsevier Science
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846781463743168512
score 12.982451

Publicaciones similares